Comparing Capecitabine Plus Oxaliplatin Versus Capecitabine Plus Oxaliplatin With Concurrent Capecitabine Radiation Therapy in Completely Resected Gastric Cancer

被引：0
|
作者：
Zhang, L. Y. [1 ]
Wu, Y. Y. [2 ]
Qian, J. J. [1 ]
Chen, L. S. [1 ]
Tian, Y. [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.828
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S316 / S316
页数：1
相关论文
共 50 条
  • [21] Oxaliplatin plus capecitabine in combination with radiation therapy for treatment of cervical cancer: A phase II study
    Levine, L.
    Hatch, S.
    Richardson, G.
    Robinson-Bennett, B.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S38 - S39
  • [22] Neoadjuvant docetaxel, oxaliplatin plus capecitabine versus oxaliplatin plus capecitabine for patients with locally advanced gastric adenocarcinoma: long-term results of a phase III randomized controlled trial
    Tian, Yuan
    Yang, Peigang
    Guo, Honghai
    Liu, Yang
    Zhang, Ze
    Ding, Pingan
    Zheng, Tao
    Deng, Huiyan
    Ma, Wenqian
    Li, Yong
    Fan, Liqiao
    Zhang, Zhidong
    Wang, Dong
    Zhao, Xuefeng
    Tan, Bibo
    Liu, Yu
    Zhao, Qun
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (12) : 4000 - 4008
  • [23] Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial.
    Guo, Weijian
    Zhu, Xiaodong
    Huang, Mingzhu
    Wang, Yusheng
    Chen, Zhiyu
    Feng, Wanjing
    He, Yifu
    Zhang, Xiaowei
    Liu, Xin
    Wang, Chenchen
    Zhang, Wen
    Ying, Jieer
    Wu, Jun
    Yang, Lei
    Qin, Yanru
    Zhao, Xiaoying
    Li, Wenhua
    Zhang, Zhe
    Qiu, Lixin
    Wang, XiaoFeng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] A Study on the Tolerability of Capecitabine plus Oxaliplatin as Adjuvant Chemotherapy
    Nakanishi, Masayoshi
    Kuriu, Yoshiaki
    Murayama, Yasutoshi
    Arita, Tomohiro
    Kosuga, Toshiyuki
    Morimura, Ryo
    Konishi, Hirotaka
    Komatsu, Syuhei
    Shiozaki, Atsushi
    Ikoma, Hisashi
    Ichikawa, Daisuke
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Otsuji, Eigo
    ANTICANCER RESEARCH, 2016, 36 (04) : 1851 - 1854
  • [25] Capecitabine and oxaliplatin (XEOLX) in adjuvant gastric cancer
    Bounedjar, A.
    ANNALS OF ONCOLOGY, 2016, 27 : 87 - 87
  • [26] Risk Factors for Thrombocytopenia Induced by Capecitabine Plus Oxaliplatin Therapy in Patients With Colorectal Cancer
    Kato, Nanami
    Nakai, Tsuyoshi
    Kodama, Sachiyo
    Koyama, Sachiko
    Nakane, Shigeki
    Wada, Yasuhiro
    Oda, Hiroshi
    Katayama, Hiromi
    Mase, Hiroki
    Miyagawa, Yasuhiro
    Miyazaki, Masayuki
    Yamada, Shigeki
    Yamada, Kiyofumi
    IN VIVO, 2024, 38 (03): : 1243 - 1252
  • [27] Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction
    R Baird
    A Biondo
    V Chhaya
    J McLachlan
    A Karpathakis
    S Rahman
    Y Barbachano
    D Cunningham
    I Chau
    British Journal of Cancer, 2011, 104 : 43 - 50
  • [28] Comparison of efficacy and safety of capecitabine and oxaliplatin (CAPOX) with epirubicin, oxaliplatin plus capecitabine (EOX) as first line treatment for advanced gastric cancer (AGC), a randomized clinical study
    Kayal, Smita
    Pani, Chinmaya Kumar
    Biswajit, Dubashi
    Verma, Surendrakumar
    Sistla, Sarath Chandra
    Cyriac, Sunu Lazar
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction
    Baird, R.
    Biondo, A.
    Chhaya, V.
    McLachlan, J.
    Karpathakis, A.
    Rahman, S.
    Barbachano, Y.
    Cunningham, D.
    Chau, I.
    BRITISH JOURNAL OF CANCER, 2011, 104 (01) : 43 - 50
  • [30] RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer
    Wong, S. J.
    Winter, K.
    Meropol, N. J.
    Anne, R.
    Kachnic, L. A.
    Rashid, A.
    Watson, J. C.
    Mitchell, E. P.
    Pollock, J.
    Lee, R. J.
    Willett, C. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345